BR112023017344A2 - Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2 - Google Patents

Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2

Info

Publication number
BR112023017344A2
BR112023017344A2 BR112023017344A BR112023017344A BR112023017344A2 BR 112023017344 A2 BR112023017344 A2 BR 112023017344A2 BR 112023017344 A BR112023017344 A BR 112023017344A BR 112023017344 A BR112023017344 A BR 112023017344A BR 112023017344 A2 BR112023017344 A2 BR 112023017344A2
Authority
BR
Brazil
Prior art keywords
bcl
inhibitors
tetrahydroindolizine
carboxamide
compounds
Prior art date
Application number
BR112023017344A
Other languages
English (en)
Inventor
Vasilievich Ivachtchenko Alexandre
Alexei Pushechnikov
Andrew Orry
Nikolay Savchuk
Chun-Hung LAM Polo
Ruben Abagyan
Zenonovich PARCHINSKY Vladislav
Volodymyr Kysil
Original Assignee
Eil Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eil Therapeutics Inc filed Critical Eil Therapeutics Inc
Publication of BR112023017344A2 publication Critical patent/BR112023017344A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2. a presente invenção é geralmente direcionada a inibidores de proteínas bcl-2 úteis no tratamento de doenças e distúrbios modulados pela dita enzima e que tem a fórmula (i):
BR112023017344A 2021-03-12 2022-03-11 Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2 BR112023017344A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163160208P 2021-03-12 2021-03-12
PCT/US2022/019998 WO2022192703A1 (en) 2021-03-12 2022-03-11 Compounds having tetrahydroindolizine-1-carboxamide as bcl-2 inhibitors

Publications (1)

Publication Number Publication Date
BR112023017344A2 true BR112023017344A2 (pt) 2023-09-26

Family

ID=83195610

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017344A BR112023017344A2 (pt) 2021-03-12 2022-03-11 Compostos que têm tetra-hidroindolizina-1-carboxamida como inibidores de bcl-2

Country Status (13)

Country Link
US (1) US11697650B2 (pt)
EP (1) EP4304588A1 (pt)
JP (1) JP2024508948A (pt)
KR (1) KR20230157419A (pt)
CN (1) CN116981458A (pt)
AR (1) AR125076A1 (pt)
AU (1) AU2022233461A1 (pt)
BR (1) BR112023017344A2 (pt)
CA (1) CA3211637A1 (pt)
MX (1) MX2023010692A (pt)
TW (1) TW202302585A (pt)
UY (1) UY39670A (pt)
WO (1) WO2022192703A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2986002B1 (fr) 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008976A1 (fr) 2013-07-23 2015-01-30 Servier Lab "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
FR3008979B1 (fr) * 2013-07-23 2015-07-24 Servier Lab Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2022532335A (ja) 2019-05-14 2022-07-14 レ ラボラトワール セルヴィエ GLY101VAL突然変異を有するBCL-2媒介性ガンの処置に使用するためのBcl-2阻害剤

Also Published As

Publication number Publication date
KR20230157419A (ko) 2023-11-16
EP4304588A1 (en) 2024-01-17
UY39670A (es) 2022-07-29
US11697650B2 (en) 2023-07-11
CA3211637A1 (en) 2022-09-15
CN116981458A (zh) 2023-10-31
MX2023010692A (es) 2023-09-19
US20220289745A1 (en) 2022-09-15
WO2022192703A1 (en) 2022-09-15
TW202302585A (zh) 2023-01-16
AR125076A1 (es) 2023-06-07
AU2022233461A1 (en) 2023-09-07
JP2024508948A (ja) 2024-02-28

Similar Documents

Publication Publication Date Title
CO2023013356A2 (es) Compuestos para la inhibición de nlrp3 y usos de estos
BR112015021999A2 (pt) inibidores de indoleamina 2,3-dioxigenase (ido)
MA38483A1 (fr) Inhibiteurs de l'ido
BR112013010310A2 (pt) inibidores de acetil-coa carboxilase de lactama n1/n2
BR112012011072A2 (pt) inibidores de n1-pirazolospirocetona acetil-coa carboxilase
CO2018010504A2 (es) Inhibidores del enlace proteína-proteína de wdr5
BR112021020520A2 (pt) Inibidores da di-hidro-orotato desidrogenase
BR112020016020A8 (pt) Inibidor de atr e aplicação do mesmo
MX2022007376A (es) Fluoroalqull-oxadiazoles y sus usos.
BR112014000240A2 (pt) derivados de benzilamina como inibidores de calicreína plasmática
BR112014013963A8 (pt) compostos inibidores de metaloenzimas
BR112022000064A2 (pt) Inibidores de hpk1 e usos dos mesmos
BR112018013522A2 (pt) compostos inibidores de metaloenzima
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BR112013031402A2 (pt) derivados de hidantoína como inibidores de kv3
EA200800777A1 (ru) Применение сложных эфиров молочной кислоты для улучшения действия пестицидов
BR112023025358A2 (pt) Inibidores de protease como antivirais
EA201291055A1 (ru) Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний
GT201700220A (es) Derivados de pirazol útiles como inhibidores de proteína activadora de 5-lipoxigenasa (flap)
CO2023017082A2 (es) Compuestos de tiadiazolilo unidos a un átomo de oxígeno como inhibidores de dna polimerasa θ
BR112022015110A2 (pt) Compostos e usos dos mesmos
MX2018008903A (es) COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
BR112022015109A2 (pt) Compostos e usos dos mesmos
BRPI0713743B8 (pt) composto, e, composição farmacêutica
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit